How to innovate in medicine in a university setting? Biocube iÌ?stanbul bioentrepreneurship and innovation center as a global case example

5^th Annual Conference on Stroke and Neurological Disorders

November 12-13, 2018 Istanbul, Turkey

Yavuz Selim SILAY,Ali Kurt

ICG (Istanbul Consulting Group), Turkey

Aydin University, Turkey

Scientific Tracks Abstracts: J Neurol Disord

Abstract :

Large Pharmaceutical, Biotech and Medical Device companies are constantly evaluating how to work with universities and startup companies and utilize their know how. Istanbul Consulting Group recently worked with Istanbul Aydın University to establish a thematic program in Healthcare Bioentrepreneurship which has taken the road with the slogan of "Towards a Bright Future", at the brightest spots of business life. Istanbul Aydın University is a city and campus university located in the center of Istanbul with its experienced academic staff who have gained a reputation for their scientific studies globally. At BioCube İstanbul several healthcare startup companies are flourishing thanks to the coordination of Technology Transfer and Project Managament offices succesful coordination on innovation management with all key stakeholders To gain these critical insights for Thematic Management of Healthcare Bioentrepreneurship and Innovation Track in Universities and how to accelerate innovations in order to improve healthcare. We seek to empower entrepreneur academicians, doctors, other healthcare providers and with the information, resources, connections, and experience they need to commercialize their ideas, inventions and discoveries. Currrent Trends in Innovation Management in Medicine in a University Setting and the BioCube İstanbul Bioentrepreneurship and Innovation Centeras a global case for USA Europe Turkey and Emerging Markets will be provided with unique cases. Dr. Ali Kurt a global innovation management leader and Dr. Yavuz Selim SILAY a global physician leader and seasoned expert in Healthcare Innovation, Physician Entrepreneurship, Government engagement, Commercial Diplomacy, Corporate Communications, Government affairs & Medical Affairs will discuss how BioCube İstanbul has been established and current engagements with academicians Venture Capital and angel Investtment networks for commercializing healthcare technologies will be discussed.

Biography :

Yavuz Selim SILAY is the chairman of Istanbul Consulting Group. ICG(Istanbul Consulting Group) was founded in 2013 and provided guidance to the Turkish ministry of health as part of a World Bank project.Yavuz is currently the Co-Founder of BioCube İstanbul Bioentrepreneurship & Innovation Center and Corporate Communication Director of Sumitomo Group/ Expel İlaç Archem Diagnostices Endmed and Diagen. He previously managed the largest distributor of Siemens Healthcare in Turkey managing 250 employees and director of Avcılar Hospital R&D Center, Chief Medical Officer of Lifematrix GmbH. Previously he worked as the Market Access & Health Policy Director for AIFD in Turkey. Yavuz Selim SILAY previously worked as the Vice President of Ipsen pharmaceutical and Director of Teva pharmaceutical in USA managing large clinical trials as well as Investigator Initiated Trials and developing relationships with Key Opinion Leaders. Previously, Yavuz was the Associate Director at KV Pharmaceuticals and Director in Clinical Development department at Forest Laboratories.

E-mail: ysilay@icg.ist